Document Detail


Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report.
MedLine Citation:
PMID:  11473947     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Gonadotrophin-releasing hormone (GnRH) antagonists have been proven safe and effective, with no adverse effects on offspring in animal studies. Careful study of pregnancy outcome in humans is mandatory. METHODS AND RESULTS: This preliminary report includes follow-up data of patients treated with the GnRH antagonist, ganirelix, during ovarian stimulation for IVF or ICSI. In total, 333 patients were randomized in a multicentre, double-blind, dose-finding study of ganirelix, at six different doses ranging from 0.0625 to 2 mg. In total, 68 vital intrauterine pregnancies were established that resulted in the birth of 46 singletons, 12 twins and one triplet. Follow-up of the 67 pregnant patients (one subject was lost to follow-up) revealed six miscarriages (9%). Of the 61 subjects with an ongoing pregnancy, two with a singleton pregnancy did not give birth to a live-born infant (one spontaneous abortion in week 19, and one intrauterine death in week 27). The mean gestational age was 39.4 weeks for singleton pregnancies, and 36.6 weeks for multiple pregnancies. In total, 73 infants (33 boys, 40 girls) were born. A birth weight <2500 g was reported for 8.7% and 54.2% of the infants resulting from singleton and twins delivery respectively. One major congenital malformation was diagnosed; a boy with Beckwith-Wiedemann syndrome (exomphalos and macroglossia). Seven minor malformations were reported among five infants. CONCLUSIONS: In this first follow-up study, the incidence of adverse obstetrical and neonatal outcome was comparable with reported incidences for IVF-embryo transfer pregnancies.
Authors:
F Olivennes; B Mannaerts; M Struijs; M Bonduelle; P Devroey
Related Documents :
23112017 - Does low-molecular-weight heparin improve live birth rates in pregnant women with throm...
12222157 - Perinatal care improves the outcome of triplets.
16439917 - Orthopaedic implications of multiple gestation pregnancy with triplets.
22190957 - Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?
3890017 - Large umbilical cord: a normal finding in some fetuses.
15601467 - Wnt1 is epistatic to id2 in inducing mammary hyperplasia, ductal side-branching, and tu...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  16     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-07-27     Completed Date:  2001-10-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  1588-91     Citation Subset:  IM    
Affiliation:
Hôpital Antoine Béclère, Service de Gynecologie-Obstétrique 157, Clamart, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Birth Weight
Congenital Abnormalities / epidemiology
Double-Blind Method
Female
Fertilization in Vitro*
Gestational Age
Gonadotropin-Releasing Hormone / administration & dosage*,  analogs & derivatives,  antagonists & inhibitors*,  therapeutic use
Hernia, Umbilical / diagnosis
Humans
Infant, Newborn
Obstetric Labor Complications / epidemiology
Ovulation Induction*
Pregnancy
Pregnancy Complications / epidemiology
Pregnancy Outcome*
Pregnancy Reduction, Multifetal
Pregnancy, Multiple
Sperm Injections, Intracytoplasmic*
Triplets
Twins
Chemical
Reg. No./Substance:
123246-29-7/ganirelix; 33515-09-2/Gonadotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: poss...
Next Document:  First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.